BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23284784)

  • 1. A mouse model for osseous heteroplasia.
    Cheeseman MT; Vowell K; Hough TA; Jones L; Pathak P; Tyrer HE; Kelly M; Cox R; Warren MV; Peters J
    PLoS One; 2012; 7(12):e51835. PubMed ID: 23284784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.
    Adegbite NS; Xu M; Kaplan FS; Shore EM; Pignolo RJ
    Am J Med Genet A; 2008 Jul; 146A(14):1788-96. PubMed ID: 18553568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNAS mutations and heterotopic ossification.
    Bastepe M
    Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterotopic ossifications in a mouse model of albright hereditary osteodystrophy.
    Huso DL; Edie S; Levine MA; Schwindinger W; Wang Y; Jüppner H; Germain-Lee EL
    PLoS One; 2011; 6(6):e21755. PubMed ID: 21747923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive osseous heteroplasia.
    Kaplan FS; Shore EM
    J Bone Miner Res; 2000 Nov; 15(11):2084-94. PubMed ID: 11092391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GNAS-associated disorders of cutaneous ossification: two different clinical presentations.
    Schimmel RJ; Pasmans SG; Xu M; Stadhouders-Keet SA; Shore EM; Kaplan FS; Wulffraat NM
    Bone; 2010 Mar; 46(3):868-72. PubMed ID: 19900597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive osseous heteroplasia, as an isolated entity or overlapping with Albright hereditary osteodystrophy.
    Lin MH; Numbenjapon N; Germain-Lee EL; Pitukcheewanont P
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):911-8. PubMed ID: 25894639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.
    Pignolo RJ; Xu M; Russell E; Richardson A; Kaplan J; Billings PC; Kaplan FS; Shore EM
    J Bone Miner Res; 2011 Nov; 26(11):2647-55. PubMed ID: 21812029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting.
    Weinstein LS; Yu S; Warner DR; Liu J
    Endocr Rev; 2001 Oct; 22(5):675-705. PubMed ID: 11588148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.
    Happle R
    Eur J Med Genet; 2016 May; 59(5):290-4. PubMed ID: 27058263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal abnormalities and extra-skeletal ossification in mice with restricted Gsalpha deletion caused by a renin promoter-Cre transgene.
    Castrop H; Oppermann M; Mizel D; Huang Y; Faulhaber-Walter R; Weiss Y; Weinstein LS; Chen M; Germain S; Lu H; Ragland D; Schimel DM; Schnermann J
    Cell Tissue Res; 2007 Dec; 330(3):487-501. PubMed ID: 17922144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minireview: GNAS: normal and abnormal functions.
    Weinstein LS; Liu J; Sakamoto A; Xie T; Chen M
    Endocrinology; 2004 Dec; 145(12):5459-64. PubMed ID: 15331575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The imprinted oedematous-small mutation on mouse chromosome 2 identifies new roles for Gnas and Gnasxl in development.
    Skinner JA; Cattanach BM; Peters J
    Genomics; 2002 Oct; 80(4):373-5. PubMed ID: 12376090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.
    McMullan P; Germain-Lee EL
    Curr Osteoporos Rep; 2022 Feb; 20(1):78-89. PubMed ID: 35226254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series.
    Elli FM; Barbieri AM; Bordogna P; Ferrari P; Bufo R; Ferrante E; Giardino E; Beck-Peccoz P; Spada A; Mantovani G
    Bone; 2013 Oct; 56(2):276-80. PubMed ID: 23796510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive osseous heteroplasia-like heterotopic ossification in a male infant with pseudohypoparathyroidism type Ia: a case report.
    Gelfand IM; Hub RS; Shore EM; Kaplan FS; Dimeglio LA
    Bone; 2007 May; 40(5):1425-8. PubMed ID: 17321228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Spindle Cell Population in a Case of Primary Osteoma Cutis With GNAS Mutation.
    Beatty C; Zinn Z; Schultz C; Lynch MC
    Am J Dermatopathol; 2020 Jun; 42(6):e72-e75. PubMed ID: 31977320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification.
    Regard JB; Malhotra D; Gvozdenovic-Jeremic J; Josey M; Chen M; Weinstein LS; Lu J; Shore EM; Kaplan FS; Yang Y
    Nat Med; 2013 Nov; 19(11):1505-12. PubMed ID: 24076664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the regulation and function of the Gs alpha gene Gnas using gene targeting technology.
    Weinstein LS; Xie T; Zhang QH; Chen M
    Pharmacol Ther; 2007 Aug; 115(2):271-91. PubMed ID: 17588669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.